Cover Story
NCI Director's Report
By Alexandria Carolan
As the likelihood of a flat budget increases for the 2024 fiscal year, NCI will have difficulty maintaining its current programs, the institute’s new director Kimryn Rathmell said in her inaugural NCI director’s report to members of the National Cancer Advisory Board Feb. 8.
In Brief
Drugs & Targets
Trending Stories
- Trump 2016: A look back at the 45th president’s impact on oncology
- As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.” - Ready or not, AI-based decision support tools are entering oncology clinics
Regulators and health systems must adapt - Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes
- MD Anderson launches Institute for Cell Therapy Discovery & Innovation